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Stimmsl~ 
The recently cloned cytotoxic lymphocyte maturation factor (interleukin 12 [IL-12]) has been 
described as a growth factor for mature lymphocytes. The present study investigated whether 
purified recombinant murine IL-12 (rMulL-12) also could affect the proliferation of primitive 
bone marrow progenitor cells. Using a population of Lin-Sca-1 + murine bone marrow stem 
cells, we now demonstrate that IL-12 is a potent synergistic factor for primitive hematopoietic 
stem cells. The synergy of IL-12 was observed in single-cell cloning assays, demonstrating that 
its effects are directly mediated. Specifically, IL-12 enhanced stem cell factor-induced myelopoiesis 
of Lin-Sca-1 + cells sevenfold, and synergized with colony-stimulating factors (CSFs) to induce 
proliferation of Lin-Sca-1 + stem cells.  IL-12 increased the number of responding progenitor 
cells as well as the size of the colonies formed. IL-12 also increased colony formation of high 
proliferative potential colony-forming cells with multiple CSF combinations. The effects of IL-12 
were concentration dependent with a 50% effective dose of 2-20 and 20-200 ng/ml, resulting 
in maximum stimulation. Furthermore, a neutralizing anti-IL-12 antibody blocked the synergistic 
effects of rMulL-12. In addition, IL-12 was found to have synergistic effects on more committed 
bone marrow progenitors as well. Our results therefore suggest that in addition to being a potent 
lymphopoietic stimulator, IL-12 is a regulator of the growth of hematopoietic stem cells and 
their myeloid progeny. 
M 
ature hematopoietic cells are mostly short-lived and con- 
tinuously renewed by pluripotent hematopoietic stem 
cells capable of producing cells of all hematopoietic lineages 
(1-3). While committed progenitor cells can proliferate in res- 
ponse to individual hematopoietic growth factors (HGFs) 1 
in vitro, the most immature hematopoietic stem cells are quies- 
cent and can only be induced to optimal proliferation as a 
result of synergy between multiple HGFs (4-9).  A physio- 
logical explanation for this restrictive responsiveness could 
be that mobilization of stem cells should occur only under 
extraordinary conditions, and thereby protect the stem cell 
pool from exhaustion. Although our knowledge about HGFs 
regulating stem cell proliferation is limited, a newly identified 
stem cell factor (SCF) has been demonstrated to be the most 
potent stem cell growth factor in cooperation with the CSFs, 
IL-1  and IL-6 (4-6,  10,  11). 
The Lin-Sca-1 + cells in murine bone marrow contain the 
1  Abbreviations used in this  ~per: CLMF, cytotoxic lymphocyte maturation 
factor; HGF, hematopoietic growth factor; HPP-CFC, high proliferative 
potential colony-forming cell; rHu, recombinant human; rMu, recombinant 
routine;  rr, recombinant  rat;  SCF, stem cell factor. 
most immature hematopoietic stem cells characterized to date 
(2,  12,  13).  As few as 100 of these cells can rescue 50%  of 
lethally irradiated mice and long-term reconstitute all lineages 
in the blood (2,  12,  13).  Although some HGFs have been 
demonstrated to stimulate in vitro proliferation of Lin- Sca- 
1 + stem cells (4-6), defining novel stem cell growth factors 
still represents a major challenge. To investigate whether cyto- 
toxic lymphocyte maturation factor (CLMF; also called NK 
cell stimulatory factor or IL-12), a cytokine previously demon- 
strated to stimulate only mature lymphoid cells (14-17), also 
might affect the proliferation of murine hematopoietic stem 
cells, Lin-Sca-1 + bone marrow cells were sorted and inves- 
tigated for IL-12 responsiveness both in the presence and ab- 
sence of other HGFs. 
Materials  and Methods 
Growth Factors and Antibodies.  Purified  recombinant human 
(rHu)G-CSF, recombinant routine (rMu)GM-CSF, and recombinant 
rat  (rr)SCF  were generously supplied by Dr.  Ian K.  McNiece 
(Amgen Corp., Thousand Oaks, CA). rMuIb3 was purchased from 
Promega Corp. (Madison,  WI).  Purified rHuCSF-1  was kindly 
provided by Dr.  Michael Geier (Cetus Corp., Emeryville,  CA). 
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Institute, Cambridge, MA). Purified  rHuI1:lc~ was kindly supplied 
by Hoffmann-La Roche, Inc. (Basel, Switzerland), and rHulL-7 by 
Steven Gillis (Immunex Corp., Seattle, WA). Purified rMulb4 and 
rHulL-2 were purchased from Genzyme (Cambridge, MA). Un- 
less otherwise indicated, all growth factors were used at predeter- 
mined optimal concentrations: rMuGM-CSF, 20 ng/ml; rHuG- 
CSF, 20 ng/ml; rMu I1:3, 20 ng/ml; rHuCSF-1, 50 ng/ml; rrSCF, 
100 ng/ml; rHulbl~, 20 ng/ml; rHulb7, 100 ng/ml; rMulL-4, 
20 ng/ml; rHulL-2, 200 U/ml. A monoclonal rat anti-mouse I1:12 
was generously provided by Dr. Richard Chizzonite (Hoffmann- 
La Roche, Inc., Nutley, NJ) and an isotype-matched antibody was 
used as a control. 
Enrichment and Purification of Murine Bone Marrow Progenitor 
Cells.  Lin- bone marrow ceUs were isolated from normal C57BL 
mice, according to a previously described protocol (20). Briefly, 
low density bone marrow cells were obtained using lymphocyte 
separation medium (Nycomed, Oslo, Norway). Cells were washed 
twice in IMDM (Gibco, Paisley, UK) and resuspended in IMDM 
supplemented with 20% FCS (Sera Lab, Sussex, UK). The cells 
were incubated at 4~  for 30 rain in a cocktail of predetermined 
optimal concentrations of antibodies: RA3-6B2 (B220 antigen; 
Pharmingen, San Diego, CA),  RB6-8C5 (GR-1 antigen; Phar- 
mingen), MAC-1 (Serotec; Oxfordshire, UK), Lyt-2 (CD8; Becton 
Dickinson & Co., Sunnyvale,  CA), and L3T4 (CD4; Pharmingen). 
Cells were washed  twice and resuspended  in complete  IMDM. Sheep 
anti-rat IgG (Fc)-conjugated  immunomagnetic  beads (Dynal, Oslo, 
Norway) were added at a cell/bead ratio of 1:20, and incubated 
at 4~  for 30 min. Labeled (Lin +) cells were removed by a mag- 
netic particle concentrator (Dynal), and the Lin- cells recovered 
from the supernatant. 
Lin-Sca-1 + cells were purified as described by others (2,  12). 
Briefly, 4-6  x  107 Lin- ceils were resuspended per milliliter of 
complete IMDM and incubated  for 30 min on ice with either FITC- 
conjugated rat anti-mouse Ly-6A/E antibody (Pharmingen) or an 
isotype-matched control antibody. The cells were washed twice, 
and Lin-Sca-1 + cells were sorted on an Epics Elite Cell Sorter 
(Coulter Electronics, Hialeah, FL) equipped with a 488-nm tuned 
argon laser set to give a power of 15 mW, with a rate of 1,500-2,000 
cellsA. Lin- cells falling into median right angle scatter and me- 
dian to high forward scatter were analyzed for Sca-1 expression, 
and cells faUing  into both regions were selected. Light scatter was 
collected through a 488-nm band pass filter and FITC fluorescence 
was collected through a 488-nm-long pass filter and 525-nm band 
pass filter. The final recovery of Lin-Sca-1 + cells was 0.05-0.1% 
of the unfractionated bone marrow. 
Soft Agar Colony Formation.  A modification of the method de- 
scribed by Stanley  et al. (18) was used to measure colony formation 
of murine bone marrow progenitors in vitro. Low density and 
Lin- bone marrow cells were plated at 5  x  104 and 2  x  104 
cells/m1, respectively,  in IMDM containing 20% FCS and 0.3% 
sea plaque agarose (FMC Bioproducts, Naperville, IL) and incubated 
at 37~  in 5% CO2 for 7 d and scored for colony growth (>50 
cells). 
High Proliferative  Potential Colony-forming Cell (HPP-CFC) Assay. 
The HPP-CFC assay  was performed  as previously  described  by others 
(19). oe modification of  Eagle's MEM (MEM-Alpha; Gibco Labora- 
tories, Grand Island, NY) supplemented with 20% FCS (Sera Lab) 
was used for all HPP-CFC assays.  Cytokines were incorporated  into 
a 1-ml underlayer at a maximum of 3% of the culture volume, 
and cells were incorporated into a 0.5-ml overlayer. The final con- 
centration of sea plaque agarose was 0.5% in the underlayer and 
0.3% in the overlayer.  HPP-CFC colonies  were scored  as dense  colo- 
nies with a diameter of 2>0.5 mm after a 12-14-d incubation in 
5%  02,  10% CO2, and 85%  N2. 
Single-Cell Proliferation Assays.  Lin-  or  Lin-Sca-1 +  were 
seeded in Terasaki  plates (Nunc, Kamstrup, Denmark) at a concen- 
tration of one cell per well in a volume of 20 #1 complete IMDM. 
Wells were scored for proliferation (>50 cells) after 12 d incuba- 
tion at 37~  5% CO2 in air. 
Cell Phenotyping.  104 Lin-Sca-1 + cells were plated in 1 ml of 
complete IMDM and incubated for 12 d with cytokines at 37~ 
5%  CO2 in air. Cell morphology was determined after Giemsa 
staining of cytospin preparations. 
Results 
To investigate the ability of IL-12  to directly affect the 
proliferation of primitive murine bone marrow progenitors, 
single Lin-Sca-1 + cells were plated into microtiter plates in 
the presence of  purified rMulL-12 in conjunction with HGFs 
previously shown to affect stem cell growth (Table 1).  As 
shown by others (5, 6), the only single HGF capable of in- 
ducing significant proliferation of the Lin-Sca-1 + stem cells 
was IL-3. While IL-12 did not stimulate any proliferation 
alone, it synergized with a number of the HGFs investigated 
(Table 1). In particular,  the frequency of Lin-Sca-1 + cells re- 
sponding to SCF with colony formation was enhanced from 
1:100 to 1:12, representing an 8.3-fold increase in responding 
cells. In comparison, IL-1, a well-characterized synergistic 
factor, enhanced SCF-induced colony formation 267% (Table 
1), while SCF combined with IL-3, GM-CSF, G-CSF,  and 
CSF-1  resulted in a synergistic increase in colony numbers 
of 296, 547, 1145, and 342%, respectively (not shown). The 
IL-12-induced synergy on SCF-stimulated proliferation of 
Lin-Sca-1 + stem cells was concentration dependent, with 
an ED50 between 2 and 20 ng/ml, and maximum stimula- 
tion  observed  at  20-200  ng/ml  (Fig.  1).  A  neutralizing 
anti-mouse IL-12 mAb blocked the synergistic effect of IL- 
12, demonstrating that the observed synergistic effect was 
due to IL-12 and not possible contaminants (Table 1). In ad- 
dition, G-CSF, which alone did not induce any proliferation 
of Lin-Sca-1 +  cells,  stimulated  1:60 Lin-Sca-1 +  cells  to 
colony formation when cocultured with IL-12, while IL-12 
enhanced CSF-1- and IL-3-stimulated colony formation 150 
and 67%, respectively (Table 1). GM-CSF-stimulated colony 
formation of Lin-Sca-1 + cells  was,  however,  not  signifi- 
cantly stimulated by IL-12, and in contrast to its ability to 
synergize with myeloid HGFs, we found no evidence  that 
IL-12 could synergize with lymphoid growth factors,  such 
as  IL-2,  IL-4,  or  IL-7,  to  stimulate lymphopoiesis from 
Lin-Sca-1 + stem cells (Table 1). Finally, IL-12 synergistically 
interacted with several two-factor cytokine combinations to 
increase  colony numbers (Table 1). 
To determine whether the increased frequency of colonies 
formed in response  to IL-12 was due to an increase in the 
size of responding clones from dusters to colony size and/or 
the result of an absolute increase in total responding progen- 
itors, clones were scored based on the degree of cell prolifera- 
tion (Table 2). These experiments demonstrated that IL-12 
increased the number of responding progenitor cells as well 
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Bone Marrow  Cells 
Colonies per 
1,000 cells 
Fold 
Cytokine  -  IL-12  + IL-12  increase 
-  0  0  7 
G-CSF  0  17  NA* 
CSF-1  13  33  2.5* 
GM-CSF  10  13  1.3 
IL-3  40  67  1.7" 
SCF  10  83  8.3* 
IL-1  0  0  1 
IL-2  0  0  1 
IL-4  0  0  1 
IL-7  0  0  1 
SCF + IL-1  37  99  2.7* 
G-CSF + CSF-1  51  84  1.7' 
G-CSF + GM-CSF  30  44  1.5 
SCF + anti-IL-12  10  13  1.3 
SCF + G-CSF  124  ND  NA 
Bone marrow  cells were obtained from femurs of 20-40 C57BL mice 
and Lin-Sca-1 + cells separated as described in Materials and Methods. 
Lin-Sca-1 + cells were plated in microtiter  wells at a concentration of 
one cell per well in 20 #1 IMDM supplemented with 20%  FCS and 
predetermined optimal concentrations of purified recombinant growth 
factors as described in Materials and Methods. Wells were scored for cell 
growth (>50 cells) after a 12-14-d incubation at 37~  5% CO2 in air 
in the presence  or absence  of puriiied rMulL-12 (50 ng/ml). Rat anti-mu- 
rine IL-12 mAb was used at 50 #g/ml, and an isotype-matched control 
had no effect on IL-12-induced proliferation. The results represent the 
mean of four separate  experiments, with a minimum of 1,200 wells scored 
per group. A two-tailed binominal test was performed comparing - IL-12 
vs.  + IL-12. NA, not applicable. 
* p  ~0.001. 
t p <0.01. 
as the size of the colonies formed.  In particular, IL-12 po- 
tently enhanced the number of big colonies (covering >25% 
of the well) in combination with SCF, resulting in the for- 
mation of 0 and 43 such colonies (per 1,000 cells) in the ab- 
sence and presence of IL-12,  respectively (Table 2). 
Although the Lin-Sca-1 + cells contain the most imma- 
ture stem cell population isolated to date, some intrinsic het- 
erogeneity has been demonstrated in vitro as well as in vivo 
(13, 20). Therefore, we next investigated the ability of IL-12 
to stimulate the HPP-CFCs within the Lin-Sca-1 + popu- 
lation, since the HPP-CFC is among the most primitive stem 
cells shown  to proliferate in vitro (19,  21,  22).  While few 
or no HPP-CFCs were stimulated by the investigated growth 
factor combinations in the absence of IL12, addition of IL12 
(50 ng/ml) resulted in a potent enhancement of colony for- 
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Figure  I.  Dose-response of IL-12-induced  synergy on SCF-supported 
proliferation of Lin-Sca-1 * bone marrow cells. Lin-Sca-1 * ceUs were iso- 
lated as described in Materials and Methods and plated at a density of one 
cell per well in microtiter plates in medium supplemented with rrSCF 
100 ng/ml, and exposed to increasing concentrations of rMuIb12 as indi- 
cated. Wells were scored for colony formation (>50 cells) after a 12-14-d 
incubation at 37~  in 5% CO2 in air. Results represent mean (SEM) of 
four separate experiments. 
Table  2.  Degree of Lin-Sca-1 + Cell Proliferation in the 
Absence and Presence of IL-12 
Degree of cell 
proliferation* 
Total no.  clones 
Growth factors  1  2  3  4  5  per 1,000 cells 
G-CSF  2  0  0  0  0  2 
G-CSF + IL-12  4  9  5  0  0  18 
CSF-1  4  7  4  1  0  16 
CSF-1 + IL-12  8  10  16  5  0  39 
SCF  8  8  2  0  0  18 
SCF+IL-12  12  15  24  19  24  94 
Lin-Scaq + cells,  separated as described in Materials and Methods, were 
plated in microtiter plates at a concentration of one cell per well in 20 
/~1 IMDM supplemented with 20% FCS and predetermined optimal con- 
centrations of growth factors. Wells were scored for cell growth after 
a 12-d incubation at 37~  5% CO2 in air in the presence or absence 
of rMulL-12  (50 mg/ml). 
* Scoring criteria: 1, 10-50 cells; 2, 50 cells to 10% of well covered by 
cells; 3, cells  covering 10-25%  of well; 4, 25-50% of well covered; 5, 
>50% of well covered by cells. The results presented represent one of 
three similar experiments. mation of HPP-CFCs (Table 3), confirming that IL-12 is a 
synergistic factor for one of the earliest stem cells measurable 
in vitro. 
To determine whether IL-12 also could affect the differen- 
tiation potential of SCF,  Lin-Sca-1 + cells were grown in 
SCF in the presence or absence of IL-12 (50 ng/ml) for 14 d, 
and cytospin preparations were analyzed morphologically. 
Only granulocytes and macrophages were observed in SCF- 
stimulated cultures, and while IL-12 dramatically enhanced 
the total number of cells, it did not affect the relative content 
of granulocytes and macrophages (Table 4). These findings 
were further supported by isolation of individual Lin-Sca-1 + 
clones, demonstrating that the relative contribution of gran- 
ulocyte, macrophage, and mixed (granulocyte/macrophage) 
colonies was not influenced by IL-12 treatment (Table 5). Simi- 
larly, IL-12 did not affect the differentiation of cultures stimu- 
latedbyG-CSF +  GM-CSF or G-CSF +  CSF-1 (not shown). 
Thus,  the synergistic effects of IL-12  on Lin-Sca-1 + cell 
proliferation do not affect the ability of the cooperating my- 
eloid growth factors to stimulate myelopoietic differentiation. 
We next examined whether IL-12  also  could affect the 
growth of more committed myeloid progenitors. While IL-12 
had no stimulatory activity alone, it enhanced the colony for- 
mation of both low density and Lin- bone marrow cells in 
response to SCF, G-CSF, CSF-1, and GM-CSF, while IL-3- 
stimulated colony formation was not affected by IL-12 treat- 
ment  (Table  6).  The  stimulator/effects of rMulL-12  on 
Lin-  progenitors were directly mediated, since a similar pat- 
tern of stimulation could be observed when Lin- cells were 
plated individually (not shown). Similar results were observed 
on Lin-Sca-1- progenitors (not shown). However, the syn- 
Table  3.  The Effect of lL-12 on Lin-Sca-1 + HPP-CFC 
HPP-CFC 
Growth factors  -  IL-12  + IL-12 
scF  o  6(1)" 
SCF + IL-1  0  14(3)* 
G-CSF + CSF-1  10(2)  24(4)" 
G-CSF + GM-CSF  2(1)  8(2)* 
SCF + IL-6  0  6(1)* 
Lin-Sca-1  § cells  were separated as described in Table 1 and plated into 
a double-layer agar culture as described in Materials and Methods.  The 
top layer contained 1,000 Lin-Sca-1  § cells  in 0.3% sea plaque agarose. 
Growth factors were incorporated into the undertayer at predetermined 
optimal concentrations  (Materials and Methods).  Cultures were scored 
for HPP-CFC growth (tight colonies with a diameter >0.5 mm) after 
a 14-d incubation in 5% O2,  10% CO2, and 85% N2, at 37~  in the 
absence or presence of rMulL-12 (50 mg/ml). The results represent the 
mean (SEM) of triplicate determinations, and are representative of four 
separate experiments. A two-tailed binominal  test was performed, com- 
paring  - IL-12 vs.  + IL-12. 
*  p ~0.001. 
* p ~0.05. 
Table  4.  The Effect of lL-12 on Differentiation of SCF-stimulated 
Lin-Sca-1 + Bone Marrow Cells  in Bulk Liquid  Culture 
Growth 
factors 
Percent  Percent  Percent 
Cells/ml  blasts  granulocytes  macrophages 
SCF  8.0  x  104  3(2)  83(5)  14(6) 
SCF+IL-12  180  x  104  4(1)  87(8)  9(8) 
Lin-Sca-1  + cells were  plated  in liquid culture at  10,000 cells/ml in 
IMDM with 20% FCS and rrSCF 100 ng/ml in the presence or absence 
of purified rMulL-12 (50 ng/ml). Cell morphology was determined af- 
ter Giemsa staining (Sigma Chemical Co.) of cytospin preparations from 
bulk liquid culture. Results represent mean (SEM) of three separate ex- 
periments. 
ergistic effects of IL-12 observed on these progenitor cell popu- 
lations were much less pronounced than on the Lin-Sca-1 + 
stem cells. Thus, in addition to its previously demonstrated 
effects on mature B and T cells, IL-12 is a potent synergistic 
factor for stem cells as well as committed myeloid progenitor 
cells in the bone marrow. 
Discussion 
Intensive research is still being dedicated to the isolation 
and characterization of growth factors capable of stimulating 
stem cells in bone marrow, since no defined growth factor 
combinations can stimulate these stem cells to proliferate with 
a similar potency as observed when cocultured with a stroma- 
feeder layer (23). Although there are probably multiple reasons 
for this difference, involving for instance direct stem cell- 
stroma cell interactions, it is likely that the suboptimal prolifer- 
ation of stem cells observed in response to the known HGFs 
is also partially due to the existence of additional stem cell 
growth factors yet not identified. In the present study we 
demonstrate that IL-12 is a growth factor with stem cell ac- 
tivity. The synergistic effects observed were directly medi- 
Table  5.  The Effect of lL-12 on Differentiation of SCF-stiraulated 
Individual Lin-Sca-1 + Bone Marrow Cell Colonies 
Colony  morphology 
Growth 
factors  CFU-G  CFU-M  CFU-GM 
% 
SCF  78  4  18 
SCF + IL-12  84  2  14 
Lin-Sca-l+ cells were  plated in liquid culture at one cell per well in 
IMDM with 20% FCS and rrSCF 100 ng/ml in the presence or absence 
of purified rMulL-12 (50 ng/ml). Cell morphology was determined af- 
ter Giemsa staining (Sigma Chemical Co.) of cytospin preparations  of 
individual  colonies. For both groups, a total of 60 colonies were sampled 
from three  separate experiments. 
416  Interleukin 12-induced Stimulation of Early Myelopoiesis Table  6.  The Effect of IL-12 on Colony Formation of 
Unfractionated, Low Density, and Lin-  Bone Marrow Cells 
No.  CFU-C 
Unfractionated 
CSF  IL-12  bone marrow  LDBM  Lin- 
-  -  0  0  0 
-  +  0  0  0 
G-CSF  -  ND  5(1)  8(1) 
G-CSF  +  ND  10(0)  17(1) 
CSF-1  -  21(5)  26(3)  88(4) 
CSF-1  +  30(3)  35(2)  122(12) 
GM-CSF  -  19(6)  23(2)  44(5) 
GM-CSF  +  27(3)  33(2)  61(6) 
IL-3  -  ND  16(2)  69(7) 
IL-3  +  ND  15(3)  66(3) 
SCF  -  ND  ND  34(5) 
SCF  +  ND  ND  46(7) 
Low density and Lin- bone marrow cells were separated and plated as 
described in Materials and Methods at a density of 7.5  x  104 (unfrac- 
tionated), 5  x  104 (low density), and 2  x  104 (Lin-) ceUs/ml in IMDM 
containing 20% FCS and 0.3% sea plaque agarose supplemented with 
predetermined optimal concentrations of growth factors. After a 7-d in- 
cubation (37~  5% CO2) in the absence or presence of rMulL-12 (50 
ng/ml),  cultures  were  scored for colony growth  >50  cells. Results 
represent the mean (SEM) of three separate experiments. 
ated on the hematopoietic stem cell, since single-cell cloning 
experiments demonstrated the same pattern of IL-12 response. 
The most potent synergy of IL-12 was observed in combi- 
nation with SCF, a HGF playing an important role in main- 
taining viability and inducing proliferation of the most im- 
mature stem cells (4-6, 10, 11). IL-12 increased the frequency 
of responding progenitor cells as well as the size of the colo- 
nies. The fact that IL-12 most potently stimulated the for- 
mation of large colonies in  single-cell cultures, and more 
specifically the HPP-CFC, suggests that IL-12 acts preferen- 
tially on immature progenitor cells. Furthermore, the syner- 
gistic effect of IL-12 on stem cell proliferation is very potent, 
since only the synergy observed between G-CSF and SCF 
was stronger than between IL-12 and SCF. In addition IL-12 
enhanced the proliferation of more committed myeloid pro- 
genitor cells as well. Since IL-12 only enhanced the prolifera- 
tion of Lin-Sca-1 + stem cells when combined with myeloid 
growth factors,  it was not surprising that the progeny pro- 
duced were exclusively of myeloid origin. However, since the 
Lin-Sca-1 + cells seem to be able to form only myeloid colo- 
nies under defined in vitro conditions, while under in vivo 
conditions they can form lymphoid progeny as well, we can 
not exclude that IL-12 might (under optimal conditions) in- 
duce lymphopoiesis from hematopoietic stem cells as well. 
It has been proposed that CLMF should be assigned the 
name IL-12, due to its pleiotropic effects on mature lymphoid 
cells (17).  The present study further justifies this designa- 
tion, demonstrating that IL-12 is a cytokine with pleiotropic 
effects also on the immature stem cells and committed my- 
eloid progenitors. 
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